Lisette Okkels Jensen

Showing 1-18 of 18 articles

Author Manan Pareek

Coronary interventions

10-year outcomes from a randomized comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

Pareek M, Madsen M, Warnakula Olesen KK, Jensen LO, Christiansen EH, Dalby Kristensen S, Lassen JF, Thuesen L, Bøtker H, Maeng M

August 20, 2019 | 10.4244/EIJ-D-19-00503

Author Yuki Katagiri

Coronary interventions

Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)

Katagiri Y, Onuma Y, Asano T, Iniguez A, Jensen LO, Cequier A, Hofma S, Christiansen E, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys P, Räber L, Sabaté M, Serruys P

December 7, 2018 | 10.4244/EIJ-D-18-00839

Author Kirstine Norregaard Hansen

STEMI

One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis

Hansen KN, Bendix K, Antonsen L, Veien K, Maeng M, Junker A, Christiansen EH, Kahlert J, Terkelsen C, Christensen LB, Fallesen C, Bøtker H, Jensen LO

October 19, 2018 | 10.4244/EIJ-D-17-00800

Author Julia Ellert

Interventions for heart failure

Percutaneous biventricular cardiac assist device in cardiogenic shock and refractory cardiac arrest

Ellert J, Jensen MJ, Jensen LO, Moller JE

April 6, 2018 | 10.4244/EIJ-D-17-00637

Author Christian Oliver Fallesen

How should I treat a bioresorbable vascular scaffold edge restenosis and intra-scaffold dissection?

Fallesen C, Antonsen L, Thayssen P, Jensen LO

February 20, 2018 | 10.4244/EIJ-D-17-00309

Author Lisette Okkels Jensen

Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial)

Jensen LO, Maeng M, Raungaard B, Hansen K, Kahlert J, Jensen S, Hansen H, Lassen JF, Bøtker H, Christiansen E

January 19, 2018 | 10.4244/EIJ-D-17-00731

Author Lars Jakobsen

Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents

Jakobsen L, Christiansen E, Maeng M, Hansen K, Kristensen SD, Bøtker H, Terkelsen C, Jensen S, Raungaard B, Madsen M, Lassen JF, Jensen LO

December 20, 2017 | 10.4244/EIJ-D-17-00434

Author Lorenz Räber

Coronary interventions

Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study

Räber L, Onuma Y, Brugaletta S, Garcia-Garcia H, Backx B, Iñiguez A, Jensen LO, Cequier-Fillat A, Pilgrim T, Christiansen EH, Hofma S, Suttorp M, Serruys P, Sabaté M, Windecker S

July 20, 2016 | 10.4244/EIJY15M08_03

Author Jane A. Simonsen

Coronary interventions

Outcome with invasive versus medical treatment of stable coronary artery disease: influence of perfusion defect size, ischaemia, and ejection fraction

Simonsen J, Johansen A, Gerke O, Mickley H, Thomassen A, Hess S, Rask C, Tamadoni M, Jensen LO, Hallas J, Vach W, Hoilund-Carlsen P

February 19, 2016 | 10.4244/EIJV11I10A226

Author Mikkel Hougaard

Very late stent thrombosis caused by neoatherosclerotic plaque rupture

Hougaard M, Thayssen P, Hansen H, Jensen LO

April 20, 2015 | 10.4244/EIJV10I12A251

Author Lisbeth Antonsen

Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial

Antonsen L, Thayssen P, Hansen H, Maeng M, Tilsted H, Bøtker H, Ravkilde J, Madsen M, Sørensen H, Thuesen L, Lassen JF, Jensen LO

June 20, 2014 | 10.4244/EIJV10I2A35

Author Rasmus Egede

Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial

Egede R, Jensen LO, Hansen H, Hansen K, Junker A, Thayssen P

February 22, 2013 | 10.4244/EIJV8I10A182

Author Lars Jakobsen

Sex- and age-related differences in clinical outcome after primary percutaneous coronary intervention

Jakobsen L, Niemann T, Thorsgaard N, Nielsen T, Thuesen L, Lassen JF, Jensen LO, Thayssen P, Ravkilde J, Tilsted H, Mehnert F, Johnsen SP

December 28, 2012 | 10.4244/EIJV8I8A139

Author Per Thayssen

The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation

Thayssen P, Jensen LO, Lassen JF, Tilsted H, Kaltoft A, Christiansen E, Hansen K, Ravkilde J, Maeng M, Krusell L, Madsen M, Sørensen H, Thuesen L

September 28, 2012 | 10.4244/EIJV8I5A91

Author Lisette Okkels Jensen

Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease

Jensen LO, Thayssen P, Farkas D, Hougaard M, Terkelsen C, Tilsted H, Maeng M, Junker A, Lassen JF, Horv E, Sørensen H, Thuesen L

August 24, 2012 | 10.4244/EIJV8I4A72

Author Lisette Okkels Jensen

Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial

Jensen LO, Maeng M, Thayssen P, Villadsen A, Krusell L, Bøtker H, Pedersen K, Aaroe J, Christiansen E, Vesterlund T, Hansen K, Ravkilde J, Tilsted H, Lassen JF, Thuesen L

July 29, 2011 | 10.4244/EIJV7I3A56

Author Lisette Okkels Jensen

Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes

Jensen LO, Tilsted H, Thayssen P, Kaltoft A, Maeng M, Lassen JF, Noerregaard Hansen K, Madsen M, Ravkilde J, Johnsen S, Sørensen H, Thuesen L

April 12, 2010

Author J Huisman

Between-centre reproducibility of volumetric intravascular ultrasound radiofrequency-based analyses in mild-tomoderate coronary atherosclerosis: an international multicentre study

Huisman J, Egede R, Rdzanek A, Böse D, Erbel R, Kochman J, Jensen LO, Van de Palen J, Hartmann M, Mintz G, von Birgelen C

April 12, 2010

1

Latest news

Review on Alcohol septal ablation for HOCM; the AFR-PRELIEVE trial; the ASSESS-REGURGE registry, the consensus on Imaging part 2 and more

(Cover Image: Micro-computed tomographic images for DK)

August 29, 2019

Guidance papers

EHRA/EAPCI Expert Consensus on catheter-based left atrial appendage occlusion (LAAO)

August 31, 2019

Read this weeks's JAA's on SVD following TAVI with the latest-generation balloon-expandable valves and much more

September 10, 2019

Guidance papers

Guidelines, consensus & position papers

Last Update: Augustus, PARTNER III, NOTION...

(The Trials book is supported by Biotronik)

Guidance papers

Clinical use of intracoronary imaging Part 2

Read this consensus to appraise ACS, ambiguous coronary angio findings and interventional decision-making

Last week's JAA's: EAPCI position statement on defining device success for PCI trials

September 3, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke